These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6791217)

  • 1. Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedure.
    Cooper TB; Bark N; Simpson GM
    Psychopharmacology (Berl); 1981; 74(2):115-21. PubMed ID: 6791217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
    Brunswick DJ; Amsterdam JD; Mendels J; Stern SL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):605-10. PubMed ID: 436362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva and plasma desipramine levels in Asian and Caucasian volunteers.
    Pi EH; Tran-Johnson TK; Gray GE; Walker NR; Suckow RF; Cooper TB
    Psychopharmacol Bull; 1991; 27(3):281-4. PubMed ID: 1775599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible nonlinear pharmacokinetics of desipramine after once daily dosing.
    Amsterdam JD; Brunswick DJ; Potter L; Rickels K
    Pharmacopsychiatry; 1986 Mar; 19(2):84-7. PubMed ID: 3703927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
    Cooke RG; Warsh JJ; Stancer HC; Reed KL; Persad E
    Clin Pharmacol Ther; 1984 Sep; 36(3):343-9. PubMed ID: 6467794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes.
    Spina E; Birgersson C; von Bahr C; Ericsson O; Mellström B; Steiner E; Sjöqvist F
    Clin Pharmacol Ther; 1984 Nov; 36(5):677-82. PubMed ID: 6488689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desipramine hydroxylation: variability and effect of antipsychotic drugs.
    Bock JL; Nelson JC; Gray S; Jatlow PI
    Clin Pharmacol Ther; 1983 Mar; 33(3):322-8. PubMed ID: 6130865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmethylimipramine overdose: nonlinear kinetics in a slow hydroxylator.
    Spina E; Henthorn TK; Eleborg L; Nordin C; Säwe J
    Ther Drug Monit; 1985; 7(2):239-41. PubMed ID: 4024220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting desipramine levels in children and adolescents: a naturalistic clinical study.
    Biederman J; Faraone SV; Baldessarini RJ; Flood J; Meyer M; Wilens T; Spencer T; Chen L; Weber W
    J Am Acad Child Adolesc Psychiatry; 1997 Mar; 36(3):384-9. PubMed ID: 9055519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant activity of 2-hydroxydesipramine.
    Nelson JC; Mazure C; Jatlow PI
    Clin Pharmacol Ther; 1988 Sep; 44(3):283-8. PubMed ID: 3416551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable isotope coadministration methodology for the estimation of the fraction of imipramine metabolized to desipramine.
    Sasaki Y; Shinohara Y; Baba S
    J Pharm Sci; 1990 Feb; 79(2):96-8. PubMed ID: 2324970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of imipramine after single and multiple intravenous administration in rats.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1983; 35(2):151-7. PubMed ID: 6622297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiogram changes and plasma desipramine levels during treatment of depression.
    Veith RC; Friedel RO; Bloom V; Bielski R
    Clin Pharmacol Ther; 1980 Jun; 27(6):796-802. PubMed ID: 7379448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.
    Daniel W; Adamus A; Melzacka M; Szymura J; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):209-13. PubMed ID: 7322212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating steady state desipramine levels in noninstitutionalized elderly patients using single dose disposition parameters.
    Antal EJ; Lawson IR; Alderson LM; Chapron DJ; Kramer PA
    J Clin Psychopharmacol; 1982 Jun; 2(3):193-8. PubMed ID: 7096608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desipramine in agoraphobia with panic attacks: an open, fixed-dose study.
    Lydiard RB
    J Clin Psychopharmacol; 1987 Aug; 7(4):258-60. PubMed ID: 3624509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of relationship between effect of desipramine on forced swimming test and brain levels of desipramine or its demethylated metabolite in rats.
    Mancinelli A; D'Aranno V; Borsini F; Meli A
    Psychopharmacology (Berl); 1987; 92(4):441-3. PubMed ID: 3114796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of carbamazepine on the 2-hydroxylation of desipramine.
    Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
    Psychopharmacology (Berl); 1995 Feb; 117(4):413-6. PubMed ID: 7604141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.